IL26708A - History of benzodioxane and their preparation - Google Patents
History of benzodioxane and their preparationInfo
- Publication number
- IL26708A IL26708A IL6626708A IL2670866A IL26708A IL 26708 A IL26708 A IL 26708A IL 6626708 A IL6626708 A IL 6626708A IL 2670866 A IL2670866 A IL 2670866A IL 26708 A IL26708 A IL 26708A
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- formula
- benzodioxane
- pharmaceutical composition
- group
- Prior art date
Links
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical class C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 title 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- LYKMMUBOEFYJQG-UHFFFAOYSA-N piperoxan Chemical class C1OC2=CC=CC=C2OC1CN1CCCCC1 LYKMMUBOEFYJQG-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical compound [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEM0067235 | 1965-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL26708A true IL26708A (en) | 1970-08-19 |
Family
ID=7312111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL6626708A IL26708A (en) | 1965-11-11 | 1966-10-17 | History of benzodioxane and their preparation |
Country Status (12)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056540A (en) * | 1974-01-01 | 1977-11-01 | Bristol-Myers Company | 4-Phenyl-1,3-benzodioxans |
| DE2428680C2 (de) * | 1974-06-14 | 1983-02-17 | Dr. Madaus & Co, 5000 Köln | 1-(2',4',6'-Trihydroxyphenyl)-propandion-(1,2)-Verbindungen, Verfahren zu deren Herstellung und Arzneimittel, die diese Verbindungen enthalten |
| US4146650A (en) * | 1978-04-26 | 1979-03-27 | The United States Of America As Represented By The Secretary Of Agriculture | Substituted benzodioxan sweetening compound |
| GB8526209D0 (en) * | 1985-10-23 | 1985-11-27 | Glaxo Group Ltd | Chemical process |
| AU2002306687A1 (en) * | 2001-03-13 | 2002-09-24 | Glenmark Pharmaceuticals Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1964973A (en) * | 1931-09-16 | 1934-07-03 | Winthrop Chem Co Inc | 1 (3' 4' dioxyalkylene phenyl) 2 aminoalkanol (1) |
-
1965
- 1965-11-11 DE DE1518042A patent/DE1518042C3/de not_active Expired
-
1966
- 1966-01-10 ES ES0333241A patent/ES333241A1/es not_active Expired
- 1966-09-08 CH CH1300166A patent/CH503015A/de not_active IP Right Cessation
- 1966-10-11 GB GB45397/66A patent/GB1102880A/en not_active Expired
- 1966-10-17 IL IL6626708A patent/IL26708A/en unknown
- 1966-10-25 FR FR81482A patent/FR5928M/fr not_active Expired
- 1966-10-27 NL NL6615198A patent/NL6615198A/xx unknown
- 1966-11-07 US US592319A patent/US3484448A/en not_active Expired - Lifetime
- 1966-11-09 BE BE689496D patent/BE689496A/xx unknown
- 1966-11-10 BR BR184443/66A patent/BR6684443D0/pt unknown
- 1966-11-11 DK DK586566AA patent/DK114839B/da unknown
- 1966-11-11 SE SE15446/66A patent/SE355363B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1518042A1 (de) | 1969-06-12 |
| NL6615198A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1967-05-12 |
| US3484448A (en) | 1969-12-16 |
| ES333241A1 (es) | 1967-09-01 |
| BE689496A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1967-05-19 |
| GB1102880A (en) | 1968-02-14 |
| SE355363B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1973-04-16 |
| DE1518042B2 (de) | 1974-08-22 |
| CH503015A (de) | 1971-02-15 |
| FR5928M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1968-04-01 |
| DK114839B (da) | 1969-08-11 |
| BR6684443D0 (pt) | 1973-12-18 |
| DE1518042C3 (de) | 1975-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ettlinger | Synthesis of the Natural Antithyroid Factor l-5-Vinyl-2-thioöxazolidone1 | |
| DE2700091C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPS5890526A (ja) | 新ナフタレン誘導体の製法 | |
| IL26708A (en) | History of benzodioxane and their preparation | |
| EP0074411B1 (en) | Ascorbic acid derivatives | |
| KR100406736B1 (ko) | 나프토퀴논계 화합물을 포함하는 항암제 | |
| EP0564648B1 (en) | Aconitine compound and analgesic/antiinflammatory agent | |
| JPS62209018A (ja) | 血液粘度低下剤 | |
| KR890012990A (ko) | 삼치환된 아민 이들의 제법 및 이들을 함유하는 제약조성물 | |
| JPS60120853A (ja) | １−（４′−アルキルチオフエニル）−２−アミノ−１，３−プロパンジオ−ルｎ−置換誘導体 | |
| US2040145A (en) | Beta-methylcholine derivatives and salts and processes for their production | |
| JPS609022B2 (ja) | インジルビン誘導体およびそれを含有する抗腫瘍剤 | |
| DE69018741T2 (de) | Konjugierte gamma-Hydroxybutenolid-Derivate und sie als aktiver Wirkstoff enthaltende Mittel gegen Magengeschwüre. | |
| GB1335913A (en) | Benzenesulphonyl-ureas and process for their manufacture | |
| JPS629096B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| AT376430B (de) | Verfahren zur herstellung von neuen und bekannten bicyclischen prostaglandinen und deren salzen und isomeren | |
| US3474115A (en) | Water soluble aldosterone like agents | |
| DE2702370C2 (de) | Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel | |
| US2891081A (en) | Vitamin a aldehyde derivatives and production thereof | |
| US2753340A (en) | Maleate salts of protoveratrine a and protoveratrine b | |
| US3972917A (en) | 11-Deoxy 15-methyl prostaglandin E1 | |
| IE42625B1 (en) | Thiazole-5-methanol derivatives | |
| US2351844A (en) | Chlorocaffeine nitrate and nitrite and process of making them | |
| US3467678A (en) | Tetrahydropyranyl and tetrahydrofuranyl ethers of griseofulvin and derivatives thereof | |
| US3808229A (en) | 6-oxo-tetrahydroindole derivatives |